Background and Purpose-The ABC/2 method for calculating intracerebral hemorrhage (ICH) volume has been well validated.
S pontaneous intracerebral hemorrhage (ICH) has a >40% mortality at 30 days, 1 and most survivors are left disabled. 2 Initial hemorrhage volume has been well documented as one of the variables for predicting patient outcome 3 and included in the ICH score 4 for predicting patient mortality. Moreover, ICH volume at ictus is an outcome measure and safety criterion for current clinical trials that are hoped to improve patient outcomes in future (MISTIE III [Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation], NCT01827046). 5, 6 Paramount to this work is having an accurate and expedient method for quantifying ICH volume from patient's neuroimaging. Multiple methods exist currently to perform this task, with the ABC/2 method being the most validated. 3 The ABC/2 method approximates ICH volume to the volume of an ellipsoid (4/3 πr 3 ). 3 In the formula, A=the longest diameter of hemorrhage on the largest slice of hematoma, B=the longest perpendicular diameter to A, and C=the depth of hematoma (calculated as the number of slices with hemorrhage multiplied by slice thickness). 3 Although the ABC/2 formula has been validated for small-to-moderately sized elliptical hemorrhages, 7, 8 there is still debate about the validity of the ABC/2 method in quantifying ICH in the following groups 9 16 and 2/3SC (where S=the area of largest hemorrhage on axial slice methods). [9] [10] [11] 17 We, therefore, set out to describe the agreement of the methods available to quantify ICH volume, in comparison with a reference standard semiautomatic method (which makes no assumptions about the shape of the hematoma) for calculating ICH volume in these groups from the STICH II 18 cohort.
Methods

Clinical Protocol
Participants came from STICH II-an international, prospective, multicenter, randomized trial of early surgery versus initial conservative therapy for lobar ICH at 78 sites across 27 countries. 18 Full details of original trials ethics and regulatory approval, alongside full inclusion criteria are accessible at http://www.thelancet.com/journals/lancet/ article/PIIS0140-6736(13)60986-1/fulltext. Patients in this trial were randomized to early surgery (within 48 hours) or initial conservative therapy. Patients had 2 scans in this trial, one as part of routine clinical care (diagnostic) pre-randomization and another at between 3 and 7 days later. This study assesses only those patients with open-source DICOM viewer (OsiriX Lite, v.6.5 32-bit; Pixmeo, Geneva, Switzerland) compatible CT scans, with or without contrast. For each patient, images were received with the thinnest slices provided by CT scan machines using standardized protocols in the recruiting centers. Newcastle University Ethics Committee exempted ethical approval for this study, which was conducted in accordance with the Declaration of Helsinki.
CT Analysis
Six hundred one patients were recruited in the STICH II indicating a potential 1202 scans. Patients scans were selected as described in Figure I in the online-only Data Supplement. Approximately 34% (411 scans) were not compatible with the semiautomatic segmentation in normally light office conditions using a 13-inch MacBook Pro connected to a 19-inch visual display (DELL P190S) with a bluetoothconnected mouse (Notebook mouse 5000; Microsoft). Scans were read randomly, in an order chosen by the computer, and paired scans were read blind to each other. All scans were read with window levels set to CT-Brain view (window length, 50 HU; window width, 100 HU). The area of ICH on each slice was semiautomatically delineated using the OsiriX grow region and repulsor tools. Boundaries of 40 to 80 HU were applied to define blood on CT. Particular attention was paid to avoid the inclusion of the cranium and areas of calcification in volume calculations. After accurately defining the hemorrhage, volumes were calculated by the OsiriX software and the result recorded in cubic centimeters. These are defined as region of interest (ROI) volumes.
Four arithmetic methods were tested against ROI for this study (ABC/2, ABC/2.4, ABC/3, and 2/3SC). For each, the largest slice area of hematoma (S) was identified automatically by voxel counts for each slice. Maximum diameter on this slice was measured in centimeters and recorded as the A measurement. Maximum diameter 90° to A was measured in centimeters and recorded as B. On regular slice thickness scans, C was calculated, in centimeters, as a product of the number of slices with ICH and the regular slice thickness in centimeters. Slice thickness ranged from 0.1 to 1 cm in this study. Modified ABC/2 approaches that weight the contribution of slices to the c axis based on the proportion of blood relative to the largest slice do not respect the 3 Cartesian axes fundamental to the ABC/2 method and are not recommended. 7 Arithmetic (eg, ABC/2) volumes were not simultaneously calculated to limit bias. Shape and density measures from each hematoma were measured by 1 reader (M.D.H.) as ordinal variables using the Barras et al 19 method on the largest slice of hemorrhage, where each point adds an additional shape irregularity or density heterogeneity. Categories 1 and 2 were combined and defined as regular shape or homogenous density and 3 to 5 were combined and defined as irregular or heterogeneous. The antithrombotic-associated ICH group was based on the original study data, with 79 patients on ≥1 of anticoagulants, antiplatelets, or thrombolytics premorbidly. Postoperative ICH was defined as any ICH remaining radiologically after a surgical procedure (decompression or complete evacuation). Particular attention was paid in these studies not to include any areas of the cranial bone or blood present within the intraventricular, subarachnoid, subdural, extra dural, or extra cranial spaces. In the postoperative CT scan, all intracerebral hematoma was included. Scans were examined and measured at random from the image archive. Randomization scans and 3-to 7-day scans were analyzed separately because they presented different issues. In particular, a large number of 3-to 7-day scans were post-procedure, and if there was no ICH remaining (volume=0), they were excluded.
Statistical Analysis
Differences in patient and scan characteristics between STICH II and the selected groups were assessed (Tables I and II in 
Results
Summary Characteristics
Patients at baseline were well matched with the exception of the antithrombotic-associated ICH group (Table 1) . This group had a tendency to be older and have more comorbidities. Scan characteristics ( Table 2) showed an interesting propensity for right-sided hemorrhages in the antithrombotic-associated group. Moreover, there was a greater number of frontal and occipital hemorrhages in this group, with proportionately less temporal and parietal hematomas. ROI volumes in this group were large, perhaps unsurprising because of premorbid antithrombotic use.
ICH at Randomization
374 scans at randomization were included in this analysis. Difference plots (Figure 1 having the smallest 95% limits of agreement (y=0.20x−3.12; 95% CI, +9.98 to −16.22). The ABC/2 method (A) was inferior to these 2 methods (y=0.29x−4.23; 95% CI, +14.6 to −23.07) while the ABC/3 method (C) underestimated ICH volume significantly (y=−0.13x−2.97; 95% CI, +12.54 to −18.47). Agreement to the semiautomatically segmented (ROI) volume was also assessed in the randomization group by looking at volumes calculated ≤5 mL or ≤20% of that of their ROI volume ( Figure II in the online-only Data Supplement), as used by Webb et al. 15 In this analysis, the ABC/2.4 and 2/3SC methods performed significantly (P<0.0001) better than the ABC/2 or ABC/3 method in both categories. There was a trend but not statistical significance to supporting ABC/2.4 as the most accurate method for categorizing scans within 20% of ROI volume (P=0.0723).
Postoperative ICH
Two hundred six postoperative scans were included in this study ( Figure 2 ). The ABC/3 method (C) had the smallest slope (y=0.06x−0.65; 95% CI, +12.53 to −13. 
Antithrombotic-Associated ICH
Antithrombotic-associated ICH is more frequently irregular in shape and, therefore, more prone to ICH volume estimation error. 10, 18 Seventy-nine patients at randomization were included taking ≥1 of an anticoagulant, antiplatelets, or thrombolytics (Table 1) . Of these, 24 of 79 (30.38%) were taking only an anticoagulant, 42 of 79 (53.16%) were taking only an antiplatelet, and zero (0%) patients were taking only thrombolytic. Eight (10.13%) patients were taking an anticoagulant and an antiplatelet, and 4 (5.06%) patients were on anticoagulation with a thrombolytic. Zero (0%) patients were on an antiplatelet and thrombolytic. One (1.27%) patient was taking all 3 medications described above. The ABC/2.4 method (B) had the closest agreement (y=0.03x−1.33; 95% CI, +18.84 to −21.50; Figure 3 ). The 2/3SC method (D) followed (y=0.13x−1.30; 95% CI, +11.56 to −14.15) with the smallest limits of agreement. The ABC/2 method (A) was inferior (y=0.22x−1.87; 95% CI, +20.10 to −23.85). The ABC/3 method (C) was found to considerably underestimate ICH volume in this group (y=−0.20x−0.75; 95% CI, +17.20 to −18.71).
Irregular Shaped ICH
Seven hundred three scans were included in this study that were classified as irregular shape on the largest slice of hemorrhage using the Barras ordinal groups 3 to 5 ( Table 2 ). 13.37% (94) were group 3, 24.75% (174) were group 4, and 61.88% (435) were group 5. Agreement was greatest for the ABC/2.4 method (y=0.08x−1.2; 95% CI, +16.08 to −18.48) and the 2/3SC method (y=0.17x−0.75; 95% CI, +12.69 to −14.17; Figure 4 ). ABC/3 underestimated ICH volume (y=−0.15x−0.88; 95% CI, +14.54 to −16.31), whereas ABC/2 overestimated ICH volume (y=0.27x−1.50; 95% CI, +17.29 to −20.27).
Heterogeneous-Density ICH
Six hundred fifty scans were classified as having heterogeneous density on largest slice of hemorrhage using the Barras ordinal groups 3 to 5; 23.85% (155) were group 3, 17.54% (114) were group 4, and 58.62% (381) were group 5 ( Table 2) 
Stroke
February 2018
Discussion
This study used the validated OsiriX ROI method as the reference standard against which to evaluate other methods of ICH volume estimation. We have validated the use of the ABC/2.4 method for a broad group of spontaneous supratentorial ICH. The ABC/2.4 method showed the greatest agreement for randomization of ICH volume, antithrombotic-associated, irregularly shaped, and heterogeneousdensity hemorrhages. This finding challenges the use of the ABC/2 method, having poorer agreement to ABC/2.4. Indeed, the ABC/2 method was also inferior to the 2/3SC method. However, the 2/3SC method relies on accurate measurement of the largest axial area of hemorrhage (cm 2 ) and requires segmentation software for calculation. The ABC/3 method significantly underestimated hemorrhage in all but the 3-to 7-day postsurgical group. It is interesting that the ABC/3 performed particularly poorly in this study with antithrombotic-associated hemorrhages. This is contrary to Huttner et al 16 who demonstrated closer agreement between planimetry and ABC/3 than with ABC/2 for irregular warfarin-related hemorrhages. It must be stated that our sample size in this group of antithrombotic-associated ICH was small (n=79), and our patient group was on a combination of anticoagulants, antiplatelets, and thrombolytics. However, this study did find the ABC/3 method had the closest agreement for measuring postoperative ICH volume. This finding has implications for volume reduction clinical trials in ICH, when postintervention ICH volume is an important outcome measure and safety criterion. Its clinical implication is potentially useful in patients who require reimaging after surgical evacuation. It is hypothesized by the authors that the increase in denominator seeks to account for 3-to 7-day ICH being less elliptical in shape, with any residual hematoma likely to form in a nonelliptical shape. This is supported by analysis of matched scans from pre-and post-intervention showing a nonstatistically significant trend toward increasing Barras shape and a significant trend toward decreasing Barras density at 3 to 7 days (Table I in the online-only Data Supplement).
There are several limitations to the work presented above. First, there was a selection bias to scans in the STICH II image archive that were compatible with OsiriX image viewer, this meant that more scans were from patients who had been recruited from Western centers, patients who had their initial scan at a remote center were less likely to have compatible scans. Scans were read by 1 reader (M.D.H.) after a period of training in an experienced ICH imaging laboratory, and as such, there are no intra-or interrater reliability statistics for this patient selection. Comparison with randomized ABC/2 volumes published in STICH II is not possible because of different selection criteria. The Barras shape and density are limited by only assessing the largest slice of hemorrhage and a ceiling effect with a maximum score of 5.
Conclusions
This study has validated the ABC/2.4 method for accurately calculating ICH volume across several specified groups relevant to clinical practice. This finding challenges the routine use of the ABC/2 for all but the simplest ellipsoid hemorrhages. The ABC/3 method was found to be particularly accurate for calculating postsurgical ICH volumes. 
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